Inventor · disambiguated record
Masakazu Kanamori
Also filed as: KANAMORI MASAKAZU
2 granted patents·6 pending applications·1 citations·filing 2019–2025
38Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD8
Top patents by PatentIndex Score
8 records- 0184US11312767B2Cross-species anti-latent TGF-beta 1 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Apr 26, 2022·1 cites·19 claims
- 0275US2025313617A1Cross-species anti-latent tgf-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0371US12371483B2Cross-species anti-latent TGF-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jul 29, 2025·0 cites·26 claims
- 0462US2024400665A1Cross-species anti-latent tgf-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0557US2024270853A1Anti-ddr2 antibodies and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0656US2024376190A1Anti-latent tgf-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0745US2022242944A1Antigen binding molecules that bind pdgf-b and pdgf-d and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0844US2021115122A1Cross-species anti-latent tgf-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masakazu Kanamori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →